Researchers Expected Ozempic Weight Loss to Boost Exercise. It Didn't
Researchers found 753 adults with obesity on GLP-1 drugs took 560 fewer steps a day and logged nearly 6 fewer minutes of vigorous activity.
6 Articles
6 Articles
Researchers Expected Ozempic Weight Loss to Boost Exercise. It Didn't
People taking popular GLP-1 weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound may be shedding pounds, but a new study suggests they are also moving less. People with obesity who lost weight while taking popular medications such as Ozempic, Wegovy, Zepbound, and similar drugs became significantly less physically active, according to research presented at ENDO [...]
Ozempic users may be making a major weight-loss mistake, new study suggests
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research.The study, set to be presented at ENDO 2026 (the Endocrine Society's annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, "significantly reduced" their physical activity.In an Endocrine Society press release, study lead Sajana Maharjan, MD, of HSHS St. John's Hospi…
A recent study revealed that the use of GLP-1 medications, such as Ozempic and Wegovy, is associated with a significant reduction in physical activity among patients. Despite weight loss, the data indicate that users of these drugs became less physically active after starting treatment. Impact of GLP-1 medication use on physical activity The research, presented at the Endocrine Society's annual meeting (ENDO 2026) in Chicago, suggests that while…
After starting treatment with Ozempic, Wegovy or other GLP-1 medications, patients took fewer steps and spent less time with physical activity.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
